GFAP and neurodegenerative disease: Most worryingly, are serum GFAP levels an indicator of neuroinflammatory and/or neurodegenerative diseases, or are serum GFAP levels associated with drug-induced (SSRIs) cellular toxicity (Abdelhak et al., 2022)?